Permanent chemotherapy-induced alopecia: Case report and review of the literature

被引:48
作者
Tallon, Ben [1 ]
Blanchard, Elizabeth [2 ]
Goldberg, Lynne J.
机构
[1] Boston Univ, Sch Med, Skin Pathol Lab, Dermatopathol Sect,Dept Dermatol, Boston, MA 02118 USA
[2] Tufts Univ, Sch Med, Caritas St Elizabeths Med Ctr, Boston, MA 02111 USA
关键词
BONE-MARROW TRANSPLANTATION; BREAST-CANCER; HAIR FOLLICLE; CARBOPLATIN; DOCETAXEL; CYCLOPHOSPHAMIDE; REGROWTH;
D O I
10.1016/j.jaad.2009.06.063
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Reversible alopecia following chemotherapy is well recognized and typically not evaluated by dermatologists. However, there are an increasing number of reports of permanent chemotherapy-induced alopecia, typically following high-dose chemotherapy and subsequent bone marrow transplantation. We describe an unusual case of permanent alopecia in a patient who received adjuvant chemotherapy for breast carcinoma, and not a conditioning regimen before bone marrow transplantation. A unique histologic finding of replacement of anagen hair follicles by linear columns of basaloid epithelium is reported. We review the clinical and histologic findings of permanent chemotherapy-induced alopecia and speculate on its pathogenesis. (J Am Acad Dermatol 2010;63:333-6.)
引用
收藏
页码:333 / 336
页数:4
相关论文
共 19 条
[1]   Docetaxel in combination with carboplatin for chemo-naive patients with epithelial ovarian cancer [J].
Aoki, Y ;
Sato, T ;
Tsuneki, I ;
Watanabe, M ;
Kase, H ;
Fujita, K ;
Kurata, H ;
Tanaka, K .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2002, 12 (06) :704-709
[2]  
BAKER BW, 1991, BONE MARROW TRANSPL, V7, P43
[3]  
Baselga J, 2000, SEMIN ONCOL, V27, P20
[4]   Syndecan-1 is strongly expressed in the anagen hair follicle outer root sheath and in the dermal papilla but expression diminishes with involution of the hair follicle [J].
Bayer-Garner, IB ;
Sanderson, RD ;
Smoller, BR .
AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2002, 24 (06) :484-489
[5]   'Atrophic telogen effluvium' from cytotoxic drugs and a randomized controlled trial to investigate the possible protective effect of pretreatment with a topical vitamin D3 analogue in humans [J].
Bleiker, TO ;
Nicolaou, N ;
Traulsen, J ;
Hutchinson, PE .
BRITISH JOURNAL OF DERMATOLOGY, 2005, 153 (01) :103-112
[6]   DOCETAXEL [J].
CORTES, JE ;
PAZDUR, R .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (10) :2643-2655
[7]   Relationship between irreversible alopecia and exposure to cyclophosphamide, thiotepa and carboplatin (CTC) in high-dose chemotherapy [J].
de Jonge, ME ;
Mathôt, RAA ;
Dalesio, O ;
Huitema, ADR ;
Rodenhuis, S ;
Beijnen, JH .
BONE MARROW TRANSPLANTATION, 2002, 30 (09) :593-597
[8]  
Dorr VJ, 1998, SEMIN ONCOL, V25, P562
[9]  
HASSAN M, 1994, BLOOD, V84, P2144
[10]  
LJUNGMAN P, 1995, BONE MARROW TRANSPL, V15, P869